Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Review of Anticancer Therapy|July 24, 2004
Neoadjuvant chemotherapy in ovarian cancerTjoung-Won Park, Walther C KuhnOncology Research and Treatment|April 14, 2025
Prognosis and Therapy of Ovarian Cancer, Part 1: Patient Selection and Surgical Management in Advanced Ovarian Cancer - What Tools Do We Have to Make the Right Decision?Alaa El Housheimi, Sara Tato Varela, Walther C KuhnAnticancer Research|December 12, 2003
Dendritic cell-based vaccines in breast and gynaecologic cancerJuan José Hernando, Tjoung-Won Park, Walther C KuhnArchives of Gynecology and Obstetrics|July 22, 2015
Development of obstetrical and gynecological journals, 2007 to 2013: a trend analysisChristian M Domröse, Mignon-Denise Keyver-Paik, Henning Lorenzen, et al.BMC Cancer|August 6, 2011
Matched-pair analysis of patients with female and male breast cancer: a comparative analysisRobert Foerster, Frank G Foerster, Volkhard Wulff, et al.Plos One|August 15, 2014
Impact of hormone-associated resistance to activated protein C on the thrombotic potential of oral contraceptives: a prospective observational studyHeiko Rühl, Lars Schröder, Jens Müller, et al.Thrombosis Research|February 27, 2014
Tamoxifen induces resistance to activated protein CHeiko Rühl, Lars Schröder, Jens Müller, et al.Cancer Immunology, Immunotherapy : CII|January 21, 2010
Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinomaMartin Pölcher, Michael Braun, Nicolaus Friedrichs, et al.International Journal of Cancer|June 5, 2014
HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancerOliver Zivanovic, Alina Abramian, Maximilian Kullmann, et al.Pageof 1